The Department of Pharmaceutical Care & Health Systems (PCHS) advances the practice of pharmaceutical care and its role in the healthcare system for the benefit of patients & society through education, research, & service.
PCHS is dedicated to the advancement of pharmaceutical care. Pharmaceutical care was originally conceptualized by faculty within our department and continues to be an integral focus to our departmental identity. Our faculty engage in a diverse array of pharmacy practice models and services in partnership with healthcare systems, health disciplines, and the community at large to provide high-quality patient-centered care. Our faculty meet this need through patient care, practice-based research, practice innovation, and education. Learn more about our practice faculty
Faculty and trainees within our department study the pharmacy profession, patient care behaviors, government policies, and the economic, clinical, and humanistic aspects of medications. Learn more about our research and scholarship in:
- Patient Care
- Pharmaceuticals and Public Policy
- Educational Research
PCHS embraces a leadership role in curricular innovation at the College. Our faculty are serving in leadership roles that are creating new learning experiences for Doctor of Pharmacy students and modeling innovative teaching and learning strategies in a variety of courses. Learn more about our advancing education in:
- Curricular Domains
- PharmD Emphasis - Leadership
- Advancement of Experiential Education
- Innovations in Teaching
Dr. Jean Moon & Dr. Jody Lounsbery
Dr. Jean Moon and Dr. Jody Lounsbery are faculty in PCHS, College of Pharmacy at the Broadway Family Medicine Clinic. Dr. Moon is the Program Director for the Postgraduate Pharmacy Residency Program. Dr. Lounsbery is an Assistant Director for the Postgraduate Pharmacy Residency Program.
Dr. Ann Philbrick, PharmD, FCCP, BCPS, BCACP
Dr. Ann Philbrick is an associate professor in PCHS, College of Pharmacy and the department of Family Medicine and Community Health at the University of Minnesota. She is on the faculty of Woodwinds Hospital Family Medicine Residency Program and maintains her pharmacy practice at Bethesda Family Medicine Clinic.
Drugs with high-risk anticholinergic properties can lead to risks of developing serious adverse events, such as cognitive impairment, falls, dementia, and even mortality in older adults. Yet, relatively little is known about prescribing trends of high-risk anticholinergic medications in the United States of America.
Researchers in the University of Minnesota College of Pharmacy conducted a repeated cross-sectional analysis of the 2006-2015 National Ambulatory Medical Care Survey to understand more.
The Lawrence C. and Delores M. Weaver Medal is given annually to someone who supports the college and its students through service to education, the profession, research and the community.
AACP is the national organization representing pharmacy education in the United States.
PCHS in the News
The Office of Discovery and Translation (ODAT) funded eight projects this fall to improve health equity and accessibility in Minneapolis and across Minnesota. Wendy St Peter, PharmD, is leading a project to reduce medical-related disparities in African Americans with chronic kidney disease through her national initiative "Advancing Kidney Health Through Optimal Medication Management."
Stephen Schondelmeyer, PharmD, PhD, was invited to testify at a Senate Hearing of the Homeland Security & Govt. Affairs Committee. COVID-19 Part II: Evaluating the Medical Supply Chain and Pandemic Response Gaps.
Jon Schommer, MS, PhD, RPh, was named ed Editor-in-Chief of Pharmacy. In 2018, he joined Pharmacy as an associate editor. In the past 3 years, Dr. Schommer has been active in editorial work and has done an excellent job. Taking on the new role, Dr. Schommer has a message for you and all Pharmacy readers, expressing his enthusiasm and expectation of the journal. Please see: https://www.mdpi.com/2226-4787/9/2/73.
Stephen Schondelmeyer, PharmD, PhD, is a key contributor to the COVID19--CIDRAP Viewpoint: Part 6 Ensuring a Resilient US Prescription Drug Supply.
Stephen Schondelmeyer, PharmD, PhD, is quoted in a Politico story about the drug industry pushing the FDA to solve its growing inspection backlog.